Be at the forefront
of a new cancer
screening paradigm

Transform how your patients get screened with a single blood draw and digital tools. Freenome’s health system solution integrates testing and workflows to help close the gap in cancer screening.

Be at the forefront
of a new cancer
screening paradigm

Transform how your patients get screened with a single blood draw and digital tools. Freenome’s health system solution integrates testing and workflows to help close the gap in cancer screening.

Be at the forefront
of a new cancer
screening paradigm

Transform how your patients get screened with a single blood draw and digital tools. Freenome’s health system solution integrates testing and workflows to help close the gap in cancer screening.

Too many eligible patients fall through the cracks

Cancer screening relies on multiple appointments, invasive procedures, and fragmented workflows that make it hard for patients to complete screening and cumbersome for care teams to manage it.

Freenome’s health system solution enables an end-to-end solution designed to simplify the entire process, helping your system close detection gaps, streamline operations, and support earlier intervention.

Close screening gaps with a powerful pairing

Freenome’s health system solution pairs SimpleScreen™ blood-based testing with integrated digital health tools to make screening easier for patients and simpler for care teams. Together, they are designed to reduce operational friction and help more eligible patients complete screening as part of routine care.

Cancer-specific
blood-based screening

A single draw will enable personalized testing for both colorectal and lung cancer which can be conveniently completed during a routine visit.

EHR-integrated
digital health tools

Automated patient identification, education, and adherence support using native EHR functionality to reduce missed screening opportunities and streamline workflows.

Cancer screening made simple

Freenome’s health system solution is built to deliver what health systems need: higher screening completion, less operational burden, and earlier detection when it matters most.

Card 1 front
Card 2 front
Card 2 back
Card 3 front
Card 3 back

Your early access could be their early detection

As a founding partner in Freenome’s health system solution, your health system will be among the first to access Freenome’s digital health tools and SimpleScreen tests for colorectal and lung cancers.

What you'll receive as a founding partner

Support from a full Freenome
implementation team for tailored
operational workflow and integration

Opportunities for evidence generation through co-development of publications and insights
Exclusive early access to additional cancer tests as they become available
Innovation partnership with Freenome to shape the future of personalized, multi-cancer screening

Don't miss your chance for exclusive early access

Apply to be a Founding Partner today. Limited spots available.

1. NORC at the University of Chicago. (2022). Percent of Cancers Detected by Screening in the U.S. Available at https://cancerdetection.norc.org
2. Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75(1):10-45. doi:10.3322/caac.21871

You are leaving this website

By selecting this link, you are leaving the Freenome website and will be directed to another web page.